This Plain Language Summary of Publication article (PLSP) from Obstetrics and Gynaecology highlights findings from the LIBERTY clinical studies, which focused on Black/African American women who are more likely to experience uterine fibroids and more severe symptoms. The studies evaluated relugolix combination therapy, a treatment for heavy menstrual bleeding caused by fibroids, and found it effective in reducing menstrual blood loss in these women.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study’ and was published in the American Journal of Obstetrics and Gynaecology.

Visit AJOG using the link to read the original article.